Skip to content
Contact Us

Investing in Tomorrow's Breakthrough Therapies

Dare Bioventures is committed to advancing innovative drug candidates that address significant gaps in current medical treatments. Our focus is on funding and supporting biotech innovations that target areas with high unmet medical need, accelerating the path from discovery to clinical impact.

Contact Us
Biotech researchers collaborating on drug development

Our Mission & Approach

While advancing transformative therapies that enhance public health, we deliver attractive, downside-protected returns you can count on. We partner with visionary scientists and entrepreneurs, providing capital, strategic guidance, and industry expertise to accelerate breakthrough treatments from concept to clinic. Our rigorous investment process and deep sector knowledge empower us to identify and nurture transformative biotech companies committed to improving patient outcomes and redefining the future of medicine.

Women_In_Bio_2 (2)

Founder and Managing Partner

Monica Berrondo, PhD

Former biotech founder/CEO who successfully built a YC-backed company. Active Nucleate mentor and annual reviewer for NIH/NSF. Brings operator's perspective to identifying winning biotech companies through extensive founder network.

Contact Dare Bioventures

Have questions about our investment approach or want to discuss your biotech innovation? Reach out to our team to explore partnership opportunities or learn more about how we support breakthrough drug candidates addressing high unmet medical needs.